Prognostic significance of cutaneous immune-related adverse events in patients with melanoma and other cancers on immune checkpoint inhibitors - Supplement

Name: Prognostic significance of cutaneous immune-related adverse events in patients with melanoma and other cancers on immune checkpoint inhibitors - Supplement
Creator: Leah Thompson
Published: 2021-03-08T04:54:19.931Z
Keywords: Dermatology

Thompson, Leah; Chang, Michael; Polyakov, Nicole; Blum, Amy; Josephs, Nathaniel; Krasnow, Nira; Yoon, Jaewon; Li, Edward; Molina, Gabriel; Said, Jordan; Huang, Kevin; Kuchroo, Juhi; Hinton, Andrea; Chen, Steven

doi:10.17632/bjntzjsdxb.1

Prognostic significance of cutaneous immune-related adverse events in patients with melanoma and other cancers on immune checkpoint inhibitors - Supplement

Published: 8 March 2021| Version 1 | DOI: 10.17632/bjntzjsdxb.1

Contributors:

Leah Thompson, Michael Chang, Nicole Polyakov, Amy Blum, Nathaniel Josephs, Nira Krasnow, Jaewon Yoon, Edward Li, Gabriel Molina, Jordan Said, Kevin Huang, Juhi Kuchroo, Andrea Hinton, Steven Chen

Description

Supplemental File 1: Study Design and Eligibility Criteria

Prognostic significance of cutaneous immune-related adverse events in patients with melanoma and other cancers on immune checkpoint inhibitors - Supplement

Description

Files

Categories

Licence